Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shyh-Ming Yang is active.

Publication


Featured researches published by Shyh-Ming Yang.


Journal of Medicinal Chemistry | 2008

Virtual Screening to Successfully Identify Novel Janus Kinase 3 Inhibitors: A Sequential Focused Screening Approach

Xin Chen; Lawrence J. Wilson; Ravi Malaviya; Rochelle L. Argentieri; Shyh-Ming Yang

In an effort to identify novel Janus kinase 3 inhibitors, a sequential focused screening approach was adopted to search our in-house chemical database. By biologically testing only 79 selected compounds, we successfully identified 19 compounds showing IC 50 < 20 microM, with four of them in the nanomolar range. Particularly, a 3,5-disubstituted pyrazolo[4,3- d]pyrimidine scaffold emerged as a promising candidate for further lead optimization. With the advantages of efficiency and flexibility, this approach may be utilized to identify leads for other therapeutic targets.


Bioorganic & Medicinal Chemistry Letters | 2011

Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy.

Lawrence J. Wilson; Bingbing Wang; Shyh-Ming Yang; Robert H. Scannevin; Sharon L. Burke; Prabha Karnachi; Kenneth J. Rhodes; William V. Murray

The discovery of potent N-hydroxyl caprolactam matrix metalloproteinase (MMP) inhibitors (6) based on the natural product Cobactin-T (2) is described. The synthetic method, which utilizes the ring closing metathesis reaction, is compatible to provide complementary (R) and (S) enantiomers. These compounds tested against MMP-2 and 9, show that the R stereochemistry (i.e., 16), which is opposite for that found in the natural product Cobactin-T is >1000-fold more active with IC(50) values of 0.2-0.6nM against both enzymes. The variation in the incorporation of the sulfonamide enzyme recognition element (Ar(2)XAr(1)SO(2)N(R(1)), 6), along with alterations in the RCM/double bond chemistry (R(2)) provided a series of sub nanomolar MMP inhibitors. For example, compounds 16 and 34 were found to be the most potent with IC(50) values against MMP-2 and MMP-9 found to be between 0.2 and 0.6nM with 34 being the most potent compound discovered (MMP-2 IC(50)=0.39nM and MMP-9 IC(50)=0.22nM). Compounds 16 and 34 showed acceptable drug-like properties in vivo with compound 34 showing oral bioavailability.


Journal of Organic Chemistry | 2016

Synthesis of β-Substituted Cyclic Enones via Phosphonium Salt-Activated, Palladium-Catalyzed Cross-Coupling of Cyclic 1,3-Diones

Shyh-Ming Yang; Gee-Hong Kuo; Michael David Gaul; William V. Murray

Phosphonium salt-activated, Pd-catalyzed Suzuki-Miyaura and Sonogashira cross-coupling reactions of cyclic 1,3-diones in the synthesis of β-substituted cyclic enones are described. These transformations exhibit good isolated yield and high generality with respect to both substrates and coupling partners. Extension of the substrate scope to cyclic 1,3-dione equivalents, such as 2-cyanocyclohexanone (4), is also briefly examined.


Bioorganic & Medicinal Chemistry Letters | 2007

Simplified staurosporine analogs as potent JAK3 inhibitors

Shyh-Ming Yang; Ravi Malaviya; Lawrence J. Wilson; Rochelle L. Argentieri; Xin Chen; Cangming Yang; Bingbing Wang; Druie Cavender; William V. Murray


Bioorganic & Medicinal Chemistry Letters | 2008

Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs)

Yue-Mei Zhang; Xiaodong Fan; Shyh-Ming Yang; Robert H. Scannevin; Sharon L. Burke; Kenneth J. Rhodes; Paul F. Jackson


Bioorganic & Medicinal Chemistry Letters | 2008

β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 1. Design, synthesis, and lead identification

Shyh-Ming Yang; Robert H. Scannevin; Bingbing Wang; Sharon L. Burke; Lawrence J. Wilson; Prabha Karnachi; Kenneth J. Rhodes; Bharat Lagu; William V. Murray


Bioorganic & Medicinal Chemistry Letters | 2008

β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 2. Optimization of α-amino substituents

Shyh-Ming Yang; Robert H. Scannevin; Bingbing Wang; Sharon L. Burke; Zhihong Huang; Prabha Karnachi; Lawrence J. Wilson; Kenneth J. Rhodes; Bharat Lagu; William V. Murray


Tetrahedron Letters | 2008

Microwave assisted ring-opening of epoxides with N-biaryl sulfonamides in the synthesis of matrix metalloproteinase-9 inhibitors

Shyh-Ming Yang; William V. Murray


Archive | 2012

PICOLINAMIDO-PROPANOIC ACID DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS

Devraj Chakravarty; Kevin D. Kreutter; Mark T. Powell; Brian C. Shook; Fengbin Song; Guozhang Xu; Shyh-Ming Yang; Rui Zhang; Bao-Ping Zhao


Archive | 2006

Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders

Lawrence J. Wilson; William V. Murray; Shyh-Ming Yang; Cangming Yang; Bingbing Wang

Collaboration


Dive into the Shyh-Ming Yang's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge